SCHEMBL19851078

SCHEMBL19851078

Nc1ncccc1Nc1ccccccccc1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.61
KDM4E B2RXH2 4/20 0.61
GAA P10253 4/20 0.61
ALDH1A1 P00352 4/20 0.61
MEN1 O00255 2/20 0.61
KMT2A Q03164 2/20 0.61
CYP1A2 P05177 2/20 0.61
CYP2C9 P11712 2/20 0.61
CYP2C19 P33261 2/20 0.61
LMNA P02545 1/20 0.61
CYP2D6 P10635 1/20 0.61
BACE1 P56817 1/20 0.56
PRKCI P41743 1/20 0.49
ALOX15 P16050 3/20 0.47
HSD17B10 Q99714 3/20 0.47
TP53 P04637 2/20 0.47
HPGD P15428 2/20 0.47
APP P05067 1/20 0.47
SNCA P37840 1/20 0.47
BLM P54132 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10051746 1.00 MAPT (0.61) MAPTKDM4EGAAALDH1A1MEN1
SCHEMBL23954460 0.89 MAPT (0.56) MAPTKDM4EGAAALDH1A1MEN1
SCHEMBL2602410 0.83 MAPT (0.62) MAPTKDM4EGAAALDH1A1MEN1
SCHEMBL2501726 0.78 KMT2A (0.70) KDM4EMEN1KMT2ALMNABACE1
SCHEMBL2511167 0.78 GRM4 (0.47) MAPTKDM4ELMNABACE1PRKCI
SCHEMBL6689566 0.78 DHODH (0.58) MAPTKDM4EGAAALDH1A1MEN1
SCHEMBL217480 0.76 MAPT (1.00) MAPTKDM4EGAAALDH1A1MEN1
SCHEMBL29388147 0.76 MAPT (1.00) MAPTKDM4EGAAALDH1A1MEN1
Hydrochloric Acid SCHEMBL14672810 0.76 DHODH (0.56) MAPTKDM4EGAAALDH1A1MEN1
SCHEMBL22975347 0.76 SMN1; SMN2 (0.49) MAPTKDM4EGAAALDH1A1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3495362-B1 IMIDAZOPYRIDINE THIOGLYCOLIC ACID DERIVATIVE, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF UNIV SHANDONG (CN) 2021-10-27 EP disclosed
US-10399978-B2 Imidazopyridine thioglycolic acid derivatives as potent inhibitors of human urate transporter 1 SHANDONG UNIVERSITY (CN) 2019-09-03 US disclosed
EP-3495362-A1 IMIDAZOPYRIDINE THIOGLYCOLIC ACID DERIVATIVE, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF Shandong University (CN) 2019-06-12 EP disclosed
WO-2018023851-A1 IMIDAZOPYRIDINE THIOGLYCOLIC ACID DERIVATIVE, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF 山东大学 2018-02-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10399978-B2 Imidazopyridine thioglycolic acid derivatives as potent inhibitors of human urate transporter 1 SLC29A1, SLC28A1, SLC5A1 MAPT 1810/4885KDM4E 4231/4885GAA 371/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.